|
⚲
|
| Keyboard |
| Savage Brian
✚
|
|
|---|---|
| CIK # | 0002112339 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002112339] | |
| 4 | [0002112339] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Teva Pharmaceutical Industries Ltd | |
| Savage Brian |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-05 | Sell | 1,127 | $31.67 | 35,692 |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-05 | Option exercise | 3,580 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-05 | Option exercise | 3,580 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-04 | Sell | 1,489 | $32.46 | 48,333 |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-04 | Option exercise | 3,766 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-04 | Option exercise | 4,744 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-04 | Grant | 11,280 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-04 | Option exercise | 3,466 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-04 | Sell | 1,186 | $32.46 | 38,498 |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-04 | Option exercise | 4,744 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-03 | Option exercise | 3,461 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-03 | Option exercise | 3,461 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-03 | Sell | 1,274 | $32.36 | 41,227 |